Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yongquan Shenque paste is a topical Traditional Chinese Medicine (TCM) formulation developed by Shijiazhuang Nephropathy Hospital, specifically designed for the treatment of membranous nephropathy and other chronic kidney diseases. The therapy involves the application of herbal medicinal pastes to two primary acupoints: the Yongquan point (KI1) on the sole of the foot and the Shenque point (CV8) at the umbilicus. This external application method is intended to facilitate the transdermal absorption of active herbal components, which are purported to improve renal blood flow, reduce glomerular inflammation, and assist in the repair of the glomerular basement membrane. It is typically used as a complementary therapy alongside other TCM treatments like Micro-Chinese Medicine Osmotherapy to manage proteinuria and edema in nephrotic patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yongquan shenque paste.